THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Oasis Management Co Ltd.'s Holding History (CIK: 0001317904)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 727,161 Value ($000) $13,605 Avg Close $16.59 Range $13.50 - $20.33
Q3 2025
Shares 1,118,935 Value ($000) $16,336 Avg Close $12.64 Range $10.82 - $14.87
Q2 2025
Shares 1,118,935 Value ($000) $12,342 Avg Close $9.72 Range $7.90 - $11.82
Q1 2025
Shares 1,118,935 Value ($000) $9,992 Avg Close $9.31 Range $8.35 - $10.90
Q4 2024
Shares 1,115,765 Value ($000) $10,499 Avg Close $9.10 Range $7.88 - $10.26
Q3 2024
Shares 1,115,765 Value ($000) $8,993 Avg Close $8.66 Range $7.44 - $10.42
Q2 2024
Shares 1,157,965 Value ($000) $9,820 Avg Close $9.03 Range $8.13 - $10.44
Q1 2024
Shares 1,157,965 Value ($000) $10,387 Avg Close $9.27 Range $8.21 - $11.71
Q4 2023
Shares 1,006,858 Value ($000) $11,317 Avg Close $10.06 Range $8.52 - $11.57
Q3 2023
Shares 953,254 Value ($000) $8,227 Avg Close $9.65 Range $8.25 - $10.59
Q2 2023
Shares 646,273 Value ($000) $6,689 Avg Close $11.04 Range $9.98 - $12.03
Q1 2023
Shares 622,276 Value ($000) $6,752 Avg Close $10.57 Range $9.25 - $11.52
Q4 2022
Shares 296,960 Value ($000) $3,332 Avg Close $10.51 Range $9.56 - $11.83
Q3 2022
Shares 296,960 Value ($000) $3,011 Avg Close $9.37 Range $7.53 - $11.00